Rapid Micro Biosystems (RPID) Capital Expenditures (QoQ) (2020 - 2026)
Rapid Micro Biosystems (RPID) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -156.60% |
| Mar 31, 2026 | 101.74% |
| Dec 31, 2025 | -209.22% |
| Sep 30, 2025 | 379.92% |
| Jun 30, 2025 | -176.49% |
| Mar 31, 2025 | -76.14% |
| Dec 31, 2024 | 4,510.34% |
| Sep 30, 2024 | 104.95% |
| Jun 30, 2024 | -200.17% |
| Mar 31, 2024 | 379.90% |
| Dec 31, 2023 | -703.85% |
| Sep 30, 2023 | 95.09% |
| Jun 30, 2023 | -169.70% |
| Mar 31, 2023 | 112.43% |
| Dec 31, 2022 | -210.07% |
| Sep 30, 2022 | 381.25% |
| Jun 30, 2022 | -183.85% |
| Mar 31, 2022 | 113.91% |
| Dec 31, 2021 | 47.26% |
| Sep 30, 2021 | 629.79% |